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Phylogenetics of Mycoplasma 
hominis clinical strains associated 
with gynecological infections 
or infertility as disclosed by an 
expanded multilocus sequence 
typing scheme
Safa Boujemaa1, Amina Ben Allaya1, Béhija Mlik1, Helmi Mardassi2 & Boutheina Ben 
Abdelmoumen Mardassi1
To our knowledge, the phylodistribution of M. hominis clinical strains associated with various 
pathological conditions of the urogenital tract has not been explored hitherto. Here we analyzed 
the genetic diversity and phylogenetic relationships among 59 M. hominis Tunisian clinical isolates, 
categorized as gynecological infections- or infertility-associated pathotypes. For this purpose, we 
developed an expanded multilocus sequence typing (eMLST) scheme, combining the previously 
reported multilocus sequence typing (MLST) loci (gyrB, tuf, ftsY, uvrA, gap) with a new selected set 
of putative virulence genes (p120’, vaa, lmp1, lmp3, p60), referred herein to as multi-virulence-locus 
sequence typing (MVLST) loci. In doing so, M. hominis population was segregated into two distinct 
genetic lineages, which were differentially associated with each pathotype. Such a clear dichotomy was 
supported by several phylogenetic and population genetic analysis tools. Recombination was found 
to take place, but not sufficient enough to break down the overall clonal population structure of M. 
hominis, most likely as a result of purifying selection, which accommodated the most fit clones. In sum, 
and owing to the eMLST scheme described herein, we provide insightful data on the phylogenetics of 
M. hominis, arguing for the existence of genetically differentiable urogenital pathotypes.
Mycoplasma hominis, which belongs to the Mycoplasmataceae family, in the Mollicutes class, was the first myco-
plasma species isolated from humans in 19371. It resides, as a commensal, in the lower urogenital tract of healthy 
persons. Under certain circumstances, M. hominis can cause a variety of genital infections such as bacterial vag-
inosis, pelvic inflammatory disease, and cervicitis2. This microorganism seems to be associated with pregnancy 
complications and neonatal diseases3. In addition, several studies reported the pathogenic role of M. hominis 
in infertility4,5. More interestingly, this species has been linked to a wide range of extragenital infections (septic 
arthritis, endocarditis, brain abscess), especially in immunocompromised patients6–8.
To better understand the epidemiology and the mode of spread of M. hominis, several molecular typing sys-
tems have been developed. These include Pulse-Field Gel Electrophoresis (PFGE), Restriction Fragment Length 
Polymorphism (RFLP) analysis, Amplified Fragment Length Polymorphism (AFLP), and Random Amplified 
Polymorphic DNA (RADP). All these methods have revealed a high degree of both genetic and antigenic het-
erogeneity among M. hominis strains9–12. Although informative, these approaches proved to be quite difficult to 
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reproduce and standardize between laboratories13. Recently, a molecular typing method based on Multiple-Locus 
Variable-Number Tandem Repeat Analysis (MLVA) has been developed14. This method proved discriminatory 
enough to be used for large epidemiological studies, and could also be useful to address transmission dynamics 
of M. hominis at the individual level. However, there was no obvious association between the MLVA type and the 
isolate’s characteristics14. Multilocus Sequence Typing (MLST) assay, targeting housekeeping genes, was found 
faster and easier to perform, and it exhibited a higher discriminatory power than did other subtyping methods15. 
It was first proposed in 1998 for the characterization of isolates of the human pathogen Neisseria meningitidis16, 
and has subsequently been applied to the epidemiologic studies of several bacterial species including mycoplas-
mas, such as Mycoplasma agalactiae, Mycoplasma bovis, Mycoplasma pneumoniae, and Mycoplasma synoviae17–19. 
MLST results are unambiguous, highly reproducible, and portable; and hence, they can be easily comparable 
between laboratories via worldwide web databases, including MLST (http://www.mlst.net/) and PubMLST 
(http://pubmlst.org/). An MLST approach was also developed for M. hominis, and was mainly used to evaluate 
the frequency of recombination events rather than to investigate the evolutionary relationships between strains20. 
More recently, Jironkin et al., based on the genome sequence of 18 M. hominis isolates, has identified three sets of 
seven genes that could be used as minimum multilocus sequence typing schemas21.
However, as far as could be ascertained, none of the existing typing approaches has shown the potential to 
reliably categorize M. hominis isolates according to their involvement in particular pathological conditions. 
Towards this purpose, we sought here to develop an expanded multilocus sequence typing (eMLST) scheme, 
which included both housekeeping genes and a set of putative virulence loci, and to assess its ability to distinguish 
between M. hominis clinical strains associated with gynecological infections or infertility.
Results
Allelic polymorphism of housekeeping genes. The number of polymorphic sites varied from 2 (gyrB) 
to 36 (uvrA), resulting in an allelic variation of 3 (gyrB) to 11 (uvrA and tuf) (Table 1). The haplotype diversity (H) 
varied from 0.188 (gyrB) to 0.840 (gap) and the ratio dN/dS ranged from 0 (for gyrB and ftsY) to 0.0798 (for gap). 
The Tajima’s D values ranged from −0.267 (tuf) to −0.737 (gap) and showed no statistical significance, a finding 
that might be interpreted as the result of purifying selection (Table 1).
Allelic polymorphism of virulence genes. The data reporting the allelic variations are summarized in 
Table 1. The discriminatory ability of the different loci, measured as number of alleles, varied from 6 (vaa) to 
18 (lmp1). The H value ranged from 0.7 (vaa) to 0.907 (lmp1), and the ratio dN/dS varied from 0.0843 (for p60) 
to 0.2741 (for lmp3), which suggests that the virulence genes evolved under purifying selection. The Tajima’s D 
statistic varied from −0.019 (vaa) to −0.632 (lmp1).
Defining ST, VT, eST, and their distribution within clonal complexes. The 59 M. hominis isolates 
evaluated by MLST were assigned to 21 STs (Supplementary Table S1), ten of which were represented by a single 
isolate. Among STs shared by several isolates, the most frequently encountered were ST3 (11 isolates) and ST2 
(6 isolates). The eBURST analysis found one clonal complex (CC1) and six singletons (Fig. 1a). The MVLST 
scheme distinguished 29 VTs (Supplementary Table S1), the majority of which (19 of 29 VTs) consisted of a single 
isolate. The most frequently VTs were VT3 (9 isolates), VT4, and VT2 (5 isolates). eBURST analysis defined one 
major CC (CC1), four minor CCs (CC2 to CC5), and seven singletons. The main clonal complex CC1 included 
26 strains (44% of the total) that were resolved into 11 VTs. Of these, 5 and 6 VTs were associated to gynecolog-
ical infections and infertility, respectively. The remaining CCs and singletons were linked to infertility (Fig. 1b). 
eMLST analysis resulted in the delineation of 30 eSTs (Supplementary Table S1). Twenty of the eSTs (66.67%) 
were represented by a single isolate. The most frequently eSTs were eST3 (9 isolates), followed by eST2 (5 isolates) 
eST4, eST7, and eST30 (4 isolates). eBURST resolved the 30 eSTs into one major CC (CC1), four minor CCs (CC2 
to CC5), and 15 singletons. The main clonal complex CC1 contained 7 eSTs, including 15 strains (25.42% of the 
total). Within this CC, eST4 was the predicted ancestral type. Interestingly, the minimum spanning tree (MST) 
generated from eMLST data showed two separate branches: branch A which grouped all eSTs related to infertility 
Gene
Amplicon 
size (bp)
No. of 
alleles
No. of polymorphic 
sites (%)
Haplotype 
diversity (H) dN/dS Tajima’s Da
uvrA 573 11 36 (6.28) 0.839 0.0374 −0.276
gyrB 402 3 2 (0.49) 0.188 0 N/A
ftsY 435 6 13 (2.99) 0.381 0 −0.458
tuf 381 11 10 (2.62) 0.833 0.0328 −0.267
gap 570 10 28 (4.91) 0.840 0.0798 −0.737
p120′ 510 13 19 (3.72) 0.862 0.1739 −0.346
vaa 297 6 14 (4.71) 0.700 0.2558 −0.019
lmp1 249 18 23 (9.23) 0.907 0.2570 −0.632
lmp3 375 13 27 (7.18) 0.885 0.2741 −0.625
p60 297 10 13 (4.37) 0.808 0.0843 −0.435
Table 1. Nucleotide diversity of the 10 eMLST loci. N/A, not available value because there were few sequences 
to be used in the Tajima’s D test; aNone of the Tajima’s D values significantly deviated from zero (P > 0.10).
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(CC1, CC4, CC5, and 14 singletons), and branch B which grouped all eSTs related to gynecological infections 
(CC2, CC3, and eST13) (Fig. 1c).
Evaluating the discriminatory power of eMLST. The Simpson’s index of diversity (SID) of eMLST was 
0.956, which is an ideal cutoff value for a molecular typing method22. Of note, the SID of MVLST and MLST 
gene subsets yielded slightly lower values (0.954 and 0.932, respectively), thus justifying their combination in an 
Figure 1. Minimum spanning trees analysis of the 59 M. hominis isolates based on MLST (a), MVLST (b), 
and eMLST (c) data. Each circle corresponds to a distinct allelic profile, and the circle size corresponds to the 
number of isolates sharing the same profile. The circle was coded by assigning the same color to identical type of 
clinical manifestations. The shaded zones between certain groups of circles indicate that these profiles belong to 
the same CC. Numerals connecting the circles indicate the number of allelic differences between the profiles.
www.nature.com/scientificreports/
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eMLST scheme. The SID of the MVLST gene subset was very close to that of eMLST, suggesting its possible use 
at first intention, inasmuch as the highest overall congruence, as assessed by the adjusted Rand index (AR), was 
found between eMLST and MVLST (97.4%) (Table 2). However, based on the adjusted Wallace coefficient (AW), 
the eMLST scheme developed herein proved to be the most powerful and adequate to type M. hominis strains. 
Indeed, a maximal value of AW was obtained with the 10 eMLST loci combination compared to the MLST and 
MVLST gene subsets (Table 2).
Phylogenetic analyses. To infer the evolutionary relationships amongst M. hominis isolates, three phyloge-
netic trees based on the concatenated gene sequences from the MLST, MVLST, and eMLST data, were obtained 
using the Neighbor-joining (NJ) method. For the three schemes, two major lineages, A and B, were distinguished, 
yet not supported by the bootstrap analysis. The dendrogram generated from MLST data showed that the major-
ity of STs were grouped into lineage A (15 STs), and it also revealed that infertility-associated STs did not con-
stitute a distinct lineage from the gynecological infections-associated ones (Fig. 2a). Whereas, the dendrogram 
based on the concatenated sequences from the MVLST gene set, revealed an equal distribution of VTs between 
the two lineages. Specifically, lineage A was composed of strains associated only with infertility, while lineage B 
contained both types of strains (Fig. 2b). Strikingly, the NJ tree based on eMLST data revealed a convincing asso-
ciation between clinical manifestations and a particular lineage; all infertility-associated strains were clustered 
into lineage A, while all gynecological-associated strains were clustered into lineage B (Fig. 3a). This result was 
largely in agreement with the MST topology, which demonstrated two branches: branch A corresponding to line-
age A, and branch B corresponding to lineage B (Fig. 1c). Analysis of the phylodistribution of eMLST loci variants 
showed that lmp3, vaa, and particularly tuf gene alleles, evolved towards a tight association with a specific clinical 
manifestation (Supplementary Fig. S1). However, none of the MLST-, MVLST-, or eMLST-derived data could be 
correlated with the patient’s sex or the year of isolation of the clinical strains.
In order to gain deeper insights into the phylodistribution of M. hominis clinical strains, a linkage model of 
STRUCTURE software was applied to the sequence data set of the 30 eSTs. Ten runs with K values from 2 to 10 
showed maximal posterior probability at K = 2, indicating that the 30 M. hominis eSTs could be subdivided into 
2 ancestral populations or lineages (Fig. 3b). Lineage A (red) contained all infertility-associated eSTs (25 eSTs), 
and lineage B (green) comprised all gynecological infections-associated eSTs (5 eSTs). No admixture of ancestral 
sources was found between these two populations, suggesting a high homogeneity of the eSTs in each population. 
Interestingly, the two populations identified from STRUCTURE analysis were in total accordance with the two 
lineages revealed by NJ tree (Fig. 3a). These results were also consistent with the two branches revealed by the 
MST (Fig. 1c). The FST value of 0,323 (P = 0) further confirmed the high level of genetic differentiation between 
the two lineages.
Typing 
Methods
Simpson’s index of 
diversity (SID) (95% 
CI)
Adjusted Rand index (AR) (95% CI) Adjusted Wallace coefficient (AW) (95% CI)
MLST MVLST eMLST MLST MVLST eMLST
MLST 0.932 (0.904–0.960) — — — — 0.633 (0.459–0.807) 0.634 (0.460–0.807)
MVLST 0.954 (0.931–0.977) 0.759 (0.599–0.930) — — 0.948 (0.886–1.000) — 0.949 (0.888–1.000)
eMLST 0.956 (0.933–0.979) 0.776 (0.626–0.937) 0.974 (0.916–1.000) — 1.000 (1.000–1.000) 1.000 (1.000–1.000) —
Table 2. Simpson’s Index of Diversity (SID), Adjusted Rand index (AR), and Adjusted Wallace coefficient (AW) 
of the three typing schemes.
Figure 2. Neighbor-joining trees of 59 M. hominis isolates based on the concatenated sequences of MLST (a) 
and MVLST (b) data. Bootstrap values (1,000 replications) are shown at the interior branches. The branches are 
colored according to the association of STs and VTs with infertility (red) or gynecological infections (green).
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Taken together, the above-stated data suggested that M. hominis clinical strains associated with gynecological 
infections or infertility, in Tunisia, are genetically differentiable.
Recombination in M. hominis. A split decomposition analysis, searching evidence for recombination 
among the ten genes, revealed different structures in the split graphs (Supplementary Fig. S2). The split graphs for 
uvrA, gap, and p60 were network-like with parallelogram structures indicative of recombination, which was sta-
tistically confirmed by the phi-test (P < 0.05). By contrast, no recombination could be detected for tuf, lmp1, lmp3, 
ftsY, p120’, and vaa, whose phi-test P values were >0.05. For gyrB, there were too few informative characters to 
be used in the phi-test. However, strong evidence for recombination (phi-test P value < 0.05) was observed within 
and across lineages when the concatenated sequences of eSTs of the entire population were used (Table 3). Indeed, 
the split decomposition analysis of the 30 eSTs displayed network-like structure with rays of different length and 
parallelogram-shaped groupings, confirming that recombination events had occurred frequently during M. hom-
inis evolution (Fig. 4). There were two distinct clusters in the split tree, which was consistent with the NJ-derived 
tree and STRUCTURE analysis. Simultaneously, the per site recombination/mutation ratio (ρ/θ) values for all 
population and individual lineages were calculated in order to estimate the relative contributions of both recom-
bination and mutation to the evolution of M. hominis (Table 3). This ratio was below 1 for the whole population 
of M. hominis and for lineage A (0.05166 and 0.005542, respectively), indicating that recombination occurred 
much less frequently than mutation. By contrast, recombination seems to be a major driving evolutionary force 
in lineage B, since it was found to occur almost 8 times more likely than mutation.
To further assess the likelihood of recombination, we carried out a linkage disequilibrium analysis. The stand-
ardized index of association (IAS) of 0.3103 (P < 0.001) for the whole M. hominis population indicated a tendency 
of linkage disequilibrium between the alleles, a finding minimizing the role of recombination (Table 3). Moreover, 
Figure 3. Neighbor-joining (NJ) tree and ancestry of 59 M. hominis isolates. (a) Phylogenetic NJ tree obtained 
from the concatenated sequences from the 30 eSTs. Bootstrap values are indicated for all branches. The branches 
are colored according to the association of eST with infertility (red) or gynecological infections (green). (b) 
Ancestral subpopulations obtained by STRUCTURE analysis. Each bar (stacked vertically) represents 1 of 30 
eSTs, ordered on the y-axis by their positions in the NJ tree. The two subpopulations are colored in red (lineage 
A) and green (lineage B), respectively.
Population (n) phi-test
Recombination
Linkage 
disequilibrium
ρ/site θ/site ρ/θ ISA
Total (30 eSTs) P = 0 6.613 × 10−3 0.1279947 0.05166 0.3103 (P < 0.001)
Lineage A (25 eSTs) P = 0 7.284 × 10−4 0.1341623 0.005542 0.3263 (P < 0.001)
Lineage B (5 eSTs) P = 1.095E-6 6.954 × 10−2 8.806 × 10−3 7.897 0.7171 (P < 0.001)
Table 3. Results of recombination test.
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6ScienTific REPORTS |  (2018) 8:14854  | DOI:10.1038/s41598-018-33260-x
IAS value calculated separately for lineage A was also significantly different from zero (IAS = 0.3263, P < 0.001). 
However, even in case of lineage B, which was found to undergo a high recombination rate, an IAS value of 0.7171 
(P < 0.001) indicated persistence of clonally evolving eSTs over time (Table 3).
Discussion
To our knowledge, this is the first study that explored the phylodistribution of M. hominis clinical strains involved 
in distinct pathological conditions. For this purpose, we developed and assessed an eMLST scheme, combin-
ing both MLST and MVLST gene loci. While the set of MLST loci was previously reported20, the MVLST gene 
sequences were included for the first time, and have been selected based on their polymorphic nature, as previ-
ously demonstrated23–26.
The majority of strains, collected over a relatively long period of 17 years, were isolated from infertile patients 
(83%). This finding is in line with previous studies, which revealed the higher incidence of M. hominis in the 
genitourinary tract of both women and men presenting with infertility27,28.
The ten gene loci targeted in our eMLST scheme were all readily amplified by PCR, making them good can-
didates for multilocus sequence typing of M. hominis29. Despite the relatively small number of isolates included 
in this study (59 strains), 21 STs, 29 VTs, and 30 eST were distinguished by MLST, MVLST, and eMLST, respec-
tively. Such a finding lends further support to the heterogeneous nature of M. hominis, as reported previously14,21. 
Hence, it seems clearly that increased genetic diversity of M. hominis was mainly brought about by virulence 
genes, as indicated by their average of haplotype diversity of 0.83. This might be the result of their frequent expo-
sure to environmental changes. By contrast, and as expected, the average of haplotype diversity of 0.61 found 
in M. hominis housekeeping genes was comparable to other mycoplasmas species, such as Mycoplasma bovis 
(average of 0.64)17 and Mycoplasma hyorhinis (average of 0.651)30. Previous studies have confirmed that virulence 
gene-based typing schemes (MVLST) afford higher resolution than did MLST, making them the best surrogate 
approaches to carry out reliable epidemiological investigations31,32. However, neither MVLST nor MLST data 
could be unambiguously correlated with the clinical status of the studied strain collections.
Here, owing to the development of the eMLST scheme, we have been able to unambiguously elucidate the 
genetic relatedness of 59 M. hominis strains and their clear categorization into two distinct lineages, with each 
corresponding to a specific pathotype. Indeed, all infertility-associated strains fell into one lineage (lineage A), 
while all gynecological infections-associated strains belonged to another separate lineage (lineage B). Such a clear 
distinction between the two pathotypes could not be established either by MLST or MVLST gene sets-derived 
data. This finding was consistent with the conclusions drawn from previous studies, showing that the combi-
nation of housekeping and virulence genes provides a more convenient tool for studying the epidemiology of 
pathogenic bacteria. For example, the combination of MLST and MVLST analyses of Vibrio cholerae was able to 
differentiate toxigenic from non-toxigenic strains31. Moreover, a correlation between ureaplasma subgroup 2 and 
genitourinary tract disease outcomes has been revealed by an eMLST scheme33.
The segregation of M. hominis pathotypes into two distinct genetic lineages may help to identify pathogenicity 
determinants which might locate to lineage-specific genetic changes. However, the eMLST scheme developed 
herein should be tested on larger, clinically and geographically diverse, strain collections to confirm its promising 
value.
Our data indicate that despite an overall clonal evolution of M. hominis population, recombination could 
play a role in generating diversity, as previously suggested20. This was particularly noticeable within lineage B 
Figure 4. Split network analysis based on the concatenated sequences of 30 eSTs identified among 59 M. 
hominis isolates by neighbor-net method.
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(gynecological infections-associated pathotype), since recombination was found to occur more frequently than 
mutation, a finding in sharp contrast with the mutation-driven evolution of lineage A (infertitlity-associated 
pathotype). However, both lineages displayed ISA values indicative of significant linkage disequilibrium between 
their respective eSTs suggesting a clonal population structure. The observed recombination within lineage B is 
irreconcilable with a strictly clonal population structure. Theoretically, a clonal population structure under a high 
rate of recombination can be observed due to non-random and limited sampling, as in this case. Furthermore, 
estimation of linkage disequilibrium using a single representative from each of the 5 eSTs indicated slightly lower 
but still significant non-zero ISA values, excluding the hypothesis of an epidemic population structure34. The clonal 
population structure of M. hominis is also supported by the observation that the same genotypes are repeatedly 
isolated over the years. For example, eST3, which is the most frequent genotype, was represented by isolates from 
temporally separated periods (2004–2016), suggesting that this type may be more fit than other potential variants. 
A recent study has also highlighted the existence of Ureaplasma urealyticum specific epidemic clonal lineages that 
are more likely to be transmitted between infertile couples and to be associated with clinical manifestations35.
Yet, the fact that recombination did not disrupt the phylogeny of M. hominis could be explained by purifying 
selection which retrieved deleterious amino acid changes in order to preserve the functionally optimal gene 
sequence. Indeed, both housekeeping and virulence genes were found to be evolving under purifying selection 
as suggested by dN/dS ratios and the negative values of Tajima’s D statistic. This finding is not without precedent, 
since similar results have been reported for Listeria monocytogenes36 and Staphylococcus lugdunensis32. Hence, 
aside from preserving the most fit pathotype clones, purifying selection might also contribute to maintain gene 
sequences that define a given pathotype.
The main weakness of this study consists in the limited size of the sample set and the lack of geographical and 
clinical diversity. However, despite these limitations, the majority of our results (heterogeneity of M. hominis, 
occurrence of recombination, evolution of M. hominis under purifying selection, and the ability of eMLST to 
differentiate distinct genetic lineages) was in sharp concordance with previous reports12,20,23,31,33.
Conclusion
This study demonstrated the usefulness of an eMLST scheme as a phylogenetic tool that could categorize the 
pathotypic nature of M. hominis clinical strains. Inclusion of a set of putative virulence genes endowed the eMLST 
typing scheme with increased discriminatory power and biological significance. Furthermore, our study provided 
insights into the selective forces driving M. hominis evolution. The overall picture that emerged from the obtained 
data shows that M. hominis undergoes genetic diversification through the combined action of mutation and 
recombination, while preserving the pathotype distribution, and/or their most fit clones, by evolving under puri-
fying selection. These findings should prompt additional validation studies using larger, geographically diverse 
and clinically well defined, strain collections in order to thoroughly address the genetic relationship among dis-
tinct M. hominis pathotypes.
Material and Methods
Ethical clearance. No interventions were performed in this study. Only fully anonymized data were pro-
cessed, and hence no further ethical clearance was required.
Bacterial isolates. A total of 59 M. hominis isolates was collected between the years 2000 and 2017, and had 
been identified as previously described23. Of these, 49 isolates (83%) were recovered from infertile patients and 
10 strains (17%) from patients suffering from gynecological infections (Supplementary Table S2). M. hominis 
reference strain PG21 (ATCC 23114) was included in this study.
DNA extraction. For PCR, samples were prepared as described by kong et al.37. Briefly, cells from 2 ml of 
logarithmic-phase culture of each M. hominis isolate were harvested by centrifugation at 24,000 × g for 20 min. 
DNA was isolated by treatment with 200 μl of digestion buffer (10 mM Tris-HCl, pH 8.0; 0.45% Tween 20) and 
proteinase K (100 μg/ml). Lysates were incubated for 1 h at 60 °C, then for 10 min at 100 °C, and finally stored at 
−20 °C.
Development of eMLST for M. hominis typing. An eMLST scheme consisting in the combination of 
housekeeping and putative virulence gene loci was developed. The set of housekeeping genes (gyrB, tuf, ftsY, 
uvrA, gap) was previously published and used as an MLST scheme20. Here we first screened 8 known M. hominis 
putative virulence genes, p120, p120’, lmp1, lmp3, vaa, p60, p75, and p80, in order to be included in our eMLST 
scheme, as a multi-virulence-locus sequence typing (MVLST) gene subset. To be included in the MVLST gene 
subset, a gene must be (i) amplified in all strains, (ii) amplified and sequenced using a single primer pair, and (iii) 
endowed with a higher discriminatory power. Only five virulence genes (p120’, vaa, lmp1, lmp3, p60) met the 
above inclusion criteria. Hence, our eMLST scheme consisted of a 10-loci combination (gyrB, tuf, ftsY, uvrA, gap, 
p120’, vaa, lmp1, lmp3, p60).
PCR amplification and DNA sequencing. The primer sequences of each selected locus are displayed in 
Supplementary Table S3. All amplifications were performed in a final volume of 50 µl consisting of 1X PCR buffer 
(10 mM Tris-HCl, pH 8.3; 50 mM KCl) (Invitrogen, USA), 2.5 mM MgCl2 (Invitrogen, USA), 0.4 µM of each 
primer (Sigma-Aldrich, Germany), 200 µM dNTPs (Sigma-Aldrich, Germany), 1.25 U of Taq DNA polymerase 
(Invitrogen, USA), and 10 µl of treated sample. An Applied Biosystems Thermal Cycler 2720 (Life Technologies, 
USA) was set up with a first cycle of denaturation for 5 min at 94 °C, followed by 35 cycles of denaturation at 
94 °C for 0.45 min, annealing at 58 °C for 0.45 min, elongation at 72 °C for 1 min, and a final extension step of 
7 min at 72 °C. The PCR products were electrophoresed on 1.5% agarose gel and stained with ethidium bro-
mide (Sigma-Aldrich, Germany) to visualize the DNA bands, whose sizes were determined using a 100-bp DNA 
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ladder (Invitrogen, USA). PCR products were then purified with both Exonuclease I (Biolabs, England) and 
Shrimp Alkaline Phosphatase (Biolabs, England) as per manufacturer’s instructions. Sequencing reactions were 
performed using a BigDye Terminator v3.1 cycle sequencing kit (Applied Biosystems, USA), according to the 
manufacturer’s recommendations, and were run in an ABI 3130 genetic analyzer (Applied Biosystems, USA). 
Both strands from each PCR amplicon were sequenced twice.
Descriptive analysis of MLST, MVLST, and eMLST data. The nucleotide sequences obtained were 
aligned with reference sequences downloaded from GenBank by using BioEdit Sequence Alignment Editor ver-
sion 7.2.538. For each locus, distinct allele sequences were assigned an arbitrary allele number for identifica-
tion. Each isolate was characterized by a pattern of numbers defining its allelic profile: sequence type (ST) for 
MLST (uvrA, gyrB, ftsY, tuf, gap) and virulence type (VT) for MVLST (p120’, vaa, lmp1, lmp3, p60) gene sets. An 
expanded sequence type (eST) was assigned for the 10 eMLST genes of all tested strains.
Diversity analysis of nucleotide sequences. Information for each locus including the number of pol-
ymorphic sites and the haplotype diversity (H) were calculated using DnaSP genetic software version 5.139. To 
investigate whether positive or negative selection had occurred at the protein level, the average non-synonymous/
synonymous substitution rate ratio (dN/dS) was calculated. dN/dS < 1 indicates that the relative genes were mainly 
affected by purifying selection during the population evolution, dN/dS = 1 indicates neutral selection, and 
dN/dS > 1 indicates positive selection. The DnaSP software was also used to calculate Tajima’s D statistic in order 
to test the neutrality of the observed DNA polymorphisms40.
Evaluation of eMLST. The discriminatory power, the degree of congruence among different typing schemes, 
and the statistical analysis were determined via an online tool (http://www.comparingpartitions.info/). The dis-
criminatory ability was evaluated using the Simpson’s index of diversity, SID, with 95% confidence intervals, as 
described by Hunter and Gaston41. It refers to the probability that two strains sampled randomly in the collection 
belong to two different types. An index greater than 0.90 is considered desirable if the typing results are to be 
interpreted with confidence41. Concordance between eMLST and other typing schemes (MLST or MVLST) was 
calculated using the Adjusted Rand index (AR)42 and the Adjusted Wallace coefficient (AW)43. AR value close to 
0 indicates a lack of congruence between the typing schemes, while value close to 1 indicates a high level of con-
gruence. AW value indicates the probability that two strains classified as the same type by one typing scheme will 
also be classified as the same one when using the other typing scheme.
Population structure and phylogenetic analysis. To determine closely related genotypes within highly 
similar clusters, the data was analysed using the BURST version 3 algorithm implemented in the eBURST web 
server44 (http://eburst.mlst.net/). The software determined clonal complexes (CC) from the data, suggesting a 
consensus ancestral type. To analyse the 59 M. hominis strains, we applied a DLV (Double Locus Variable) criteria 
for all schemes. This means that the maximum difference allowed within the same CC was that of two loci.
Three phylogenetic trees from the concatenated sequences of MLST (2361 pb), MVLST (1728 pb), and eMLST 
(4089 bp) gene sets, and phylogenetic trees based on the allele sequences of each gene, were constructed by the 
Neighbor-Joining (NJ)45 method with a Kimura’s two-parameter distance model and 1,000 bootstrap replications 
using MEGA version 6.0646. STRUCTURE software version 2.3.447,48 with linkage model was used to identify 
the ancestral populations for each eST. The K-value that generated the highest posterior probability was used 
as the probable number of ancestral populations. Ten individual runs per value of K (chosen between 2 and 10) 
were performed using 200,000 burn-in iterations and 300,000 Markov Chain Monte Carlo (MCMC) iterations. 
The STRUCTURE Harvester49, which implements the Evanno method, was used to identify the most probable 
groups (K) that best fit the data. The K-value that generated the highest median posterior probability was used 
as the probable number of ancestral populations. We estimated the fixation index (FST) to mesure the degree of 
population differenciation using 100,000 genotypic permutations in Arlequin 3.550. In general, FST values range 
from 0 (no differentiation) to 1 (complete differentiation). Basically, an FST value of 0.05–0.15 indicates low differ-
entiation, while FST > 0.30 indicates high differentiation51.
The relationships between the eST and the clinical manifestations of all isolates were determined using a 
Minimum Spanning Tree (MST) analysis performed with BioNumerics software (version 7.0, Applied Maths).
Recombination analysis. The split network of eSTs and individual loci were generated by using 
neighbor-net method using SplitTree452. The pairwise homoplasy index (phi) test53 implemented in SplitTree4 
for recombination was performed, and the P-value < 0.05 indicated recombination existed. LDhat programme 
implemented in Recombination Detection Program (RDP) version 4.8354 was used to calculate the per site recom-
bination/mutation ratio (ρ/θ)55 based on the concatenated sequences of ten loci with 100,000 MCMC iterations. 
Linkage disequilibrium from allelic data was evaluated by calculating the standardized index of association (ISA) 
using LIAN version 3.756,57 (http://guanine.evolbio.mpg.de/cgi-bin/lian/lian.cgi.pl/query). IAS value significantly 
different from 0 indicates that a population is clonal (linkage disequilibrium), while IAS equal to zero indicates a 
recombining population structure (linkage equilibrium). IAS was tested by using Monte Carlo methods with 1,000 
iterations on allelic profile.
Nucleotide sequence accession numbers. Nucleotide sequences of the ten eMLST allelic variants were 
submitted to GenBank, and their accession numbers are provided in Supplementary Table S4.
Data Availability
All data generated and analysed during this study are included in this published article and its Supplementary 
Information file.
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